mode百度云100as
百度云100as 时间:2021-01-04 阅读:()
58HongKongMedJVol16No1#Supplement1#February2010Beta1subunit–dependentmodulationofBKchannelbymembranecholesterolWWu,CPLau,HFTse,GRLiDepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThelargeconductanceCa2+-activatedK+(BKorMaxi-K)channelsareubiquitouslyexpressedindifferenttissueswithout(brain,liver,etc)orwith(smoothmuscleandheart)regulatorybeta-subunit,andplayanimportantroleinregulatingvariousphysiologicalprocessessuchascellexcitability,hormonesecretion,vascularactivity,etc.
RecentstudieshaveshownthatmembranecholesterolisamajorregulatorofseveralpotassiumchannelsincludingKirandKv1.
5channels.
However,theregulationofBKchannelsbycholesterolisnotfullyunderstood.
Methods:WholecellBKcurrentandBKsinglechannelcurrentwererecordedinwhole-cellpatchclampmodeandcell-attachedsinglechannelrecording,respectively,inHEK293cellsstablyexpressingMaxi-KgeneorMaxi-Kwithbeta1-subunit.
Results:Wefoundthatwhole-cellBKcurrentwassignificantlysuppressedwithcholesteroldepletionbymethyl-beta-cyclodextrin(MCD),whereascholesterol-saturated–MCDhadnoeffectonthecurrentamplitude.
SinglechannelrecordingshowedthatcholesteroldepletionsignificantlyreducedtheopenprobabilityofBKchannel,suggestingthatcholesteroldepletionlikelydecreasesthemembranechannelnumber.
Interestingly,incellsstablyexpressingSloandbeta1-subunit,depletionofmembranecholesterolincreasedBKcurrent,whilecholesterol-saturated–MCDreducedBKcurrent.
Conclusion:OurresultsdemonstratetheimportantevidencethatBKchannelsexhibitbeta1-subunit–dependentresponsestocholesterol.
TheenrichedcholesterolreducestheactivityofBKchannelsco-expressedwithMax-Kandbeta1-subunit,whichmayatleastinpartaccountsfortheoccurrenceofhypertensioninpatientswithhighplasmacholesterollevel,sincebeta-subunittranscriptsareabundantinvascularsmoothmuscle.
99PhaseI/IItrialofPTK787/ZK222584combinedwithintravenousdoxorubicinfortreatmentofpatientswithadvancedhepatocellularcarcinoma:implicationforanti-angiogenicapproachtohepatocellularcarcinomaTYau1,PChan1,KKNg2,STFan2,RTPoon21DepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKong2DepartmentofSurgery,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThisisaphaseI/IItrialaimingtoassesstheefficacyandtolerabilityofPTK787/ZK222584(PTK)incombinationwithintravenousdoxorubicinforthetreatmentofadvancedhepatocellularcarcinoma(HCC)patients.
Methods:InphaseI,advancedHCCpatientsreceivedPTKatescalatingdosestogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weekstoestablishthemaximumtolerateddose(MTD).
Subsequently,inphaseII,allpatientsreceivedthesameregimenwithoralPTKattheMTDdosetogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weeksforamaximumof6cycles.
Results:Ninepatientswererecruitedinphase1partwiththeMTDestablishedas750mgdaily.
Overall,27patientsreceivedtheregimenwithPTKat750mgdaily.
Themedianagewas52(range,23-73)yearsand63%ofpatientswerechronichepatitisBcarriers.
Notably,themajorityofpatientshadChildBcirrhosis.
Theoverallresponseratewas26.
0%withallpatientshavingpartialresponse,andanother20%ofpatientsachievedstablediseaseforatleast12weeks.
Themedianprogression-freesurvivalwas5.
4(0.
27-23.
6)monthsandoverallsurvivalwas7.
3(0.
8-23.
6)months.
Thecommonestgrade3or4non-haematologicaltoxicitiesweremucositis(11%)andalopecia(7%),respectively.
Grade3or4neutropeniawasobservedinseven(26%)patientswithtwohavingneutropenicsepsis.
Conclusion:ThecombinationofPTKwithintravenousdoxorubicinshowssynergisticactivityinadvancedHCCpatients.
Thus,theideaofcombininganti-angiogenicagenttogetherwithchemotherapymaywarrantfurtherevaluationinfutureclinicaltrialsofadvancedHCCpatients.
100
RecentstudieshaveshownthatmembranecholesterolisamajorregulatorofseveralpotassiumchannelsincludingKirandKv1.
5channels.
However,theregulationofBKchannelsbycholesterolisnotfullyunderstood.
Methods:WholecellBKcurrentandBKsinglechannelcurrentwererecordedinwhole-cellpatchclampmodeandcell-attachedsinglechannelrecording,respectively,inHEK293cellsstablyexpressingMaxi-KgeneorMaxi-Kwithbeta1-subunit.
Results:Wefoundthatwhole-cellBKcurrentwassignificantlysuppressedwithcholesteroldepletionbymethyl-beta-cyclodextrin(MCD),whereascholesterol-saturated–MCDhadnoeffectonthecurrentamplitude.
SinglechannelrecordingshowedthatcholesteroldepletionsignificantlyreducedtheopenprobabilityofBKchannel,suggestingthatcholesteroldepletionlikelydecreasesthemembranechannelnumber.
Interestingly,incellsstablyexpressingSloandbeta1-subunit,depletionofmembranecholesterolincreasedBKcurrent,whilecholesterol-saturated–MCDreducedBKcurrent.
Conclusion:OurresultsdemonstratetheimportantevidencethatBKchannelsexhibitbeta1-subunit–dependentresponsestocholesterol.
TheenrichedcholesterolreducestheactivityofBKchannelsco-expressedwithMax-Kandbeta1-subunit,whichmayatleastinpartaccountsfortheoccurrenceofhypertensioninpatientswithhighplasmacholesterollevel,sincebeta-subunittranscriptsareabundantinvascularsmoothmuscle.
99PhaseI/IItrialofPTK787/ZK222584combinedwithintravenousdoxorubicinfortreatmentofpatientswithadvancedhepatocellularcarcinoma:implicationforanti-angiogenicapproachtohepatocellularcarcinomaTYau1,PChan1,KKNg2,STFan2,RTPoon21DepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKong2DepartmentofSurgery,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThisisaphaseI/IItrialaimingtoassesstheefficacyandtolerabilityofPTK787/ZK222584(PTK)incombinationwithintravenousdoxorubicinforthetreatmentofadvancedhepatocellularcarcinoma(HCC)patients.
Methods:InphaseI,advancedHCCpatientsreceivedPTKatescalatingdosestogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weekstoestablishthemaximumtolerateddose(MTD).
Subsequently,inphaseII,allpatientsreceivedthesameregimenwithoralPTKattheMTDdosetogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weeksforamaximumof6cycles.
Results:Ninepatientswererecruitedinphase1partwiththeMTDestablishedas750mgdaily.
Overall,27patientsreceivedtheregimenwithPTKat750mgdaily.
Themedianagewas52(range,23-73)yearsand63%ofpatientswerechronichepatitisBcarriers.
Notably,themajorityofpatientshadChildBcirrhosis.
Theoverallresponseratewas26.
0%withallpatientshavingpartialresponse,andanother20%ofpatientsachievedstablediseaseforatleast12weeks.
Themedianprogression-freesurvivalwas5.
4(0.
27-23.
6)monthsandoverallsurvivalwas7.
3(0.
8-23.
6)months.
Thecommonestgrade3or4non-haematologicaltoxicitiesweremucositis(11%)andalopecia(7%),respectively.
Grade3or4neutropeniawasobservedinseven(26%)patientswithtwohavingneutropenicsepsis.
Conclusion:ThecombinationofPTKwithintravenousdoxorubicinshowssynergisticactivityinadvancedHCCpatients.
Thus,theideaofcombininganti-angiogenicagenttogetherwithchemotherapymaywarrantfurtherevaluationinfutureclinicaltrialsofadvancedHCCpatients.
100
Sharktech（$49/月），10G端口 32GB内存，鲨鱼机房新用户赠送$50
Sharktech 鲨鱼机房商家我们是不是算比较熟悉的，因为有很多的服务商渠道的高防服务器都是拿他们家的机器然后部署高防VPS主机的，不过这几年Sharktech商家有自己直接销售云服务器产品，比如看到有新增公有云主机有促销活动，一般有人可能买回去自己搭建虚拟主机拆分销售的，有的也是自用的。有看到不少网友在分享到鲨鱼机房商家促销活动期间，有赠送开通公有云主机$50，可以购买最低配置的，$49/月的...
Virmach（$5.23/年）年付VPS闪购
每每进入第四季度，我们就可以看到各大云服务商的促销力度是一年中最大的。一来是年底的促销节日活动比较多，二来是商家希望最后一个季度冲刺业绩。这不还没有到第四季度，我们看到有些商家已经蠢蠢欲动的开始筹备活动。比如素有低价VPS收割机之称的Virmach商家居然还没有到黑色星期五就有发布黑五促销活动。Virmach 商家有十多个数据中心，价格是便宜的，但是机器稳定性和速度肯定我们也是有数的，要不这么低的...
无视CC攻击CDN ,DDOS打不死高防CDN,免备案CDN,月付58元起
快快CDN主营业务为海外服务器无须备案，高防CDN，防劫持CDN，香港服务器，美国服务器，加速CDN，是一家综合性的主机服务商。美国高防服务器，1800DDOS防御，单机1800G DDOS防御，大陆直链 cn2线路，线路友好。快快CDN全球安全防护平台是一款集 DDOS 清洗、CC 指纹识别、WAF 防护为一体的外加全球加速的超强安全加速网络，为您的各类型业务保驾护航加速前进！价格都非常给力，需...
百度云100as为你推荐
-
域名代理如何知道自己的域名是在哪个代理商注册的啊？租服务器租服务器是什么意思？虚拟主机推荐虚拟主机哪个好免费国外空间哪里的国外免费空间好？便宜的虚拟主机低价虚拟主机那种类型的好呢？100m虚拟主机100元虚拟主机虚拟主机管理系统大家都用的是什么虚拟主机管理系统？分享一下西安虚拟主机如何评价虚拟主机的优劣虚拟主机排名IDC全国十强是哪几个服务商广西虚拟主机江西服务器托管，但要接入专线，问了很多代理都说不可以，如何解决？